治療用抗体：方法・プロトコル Therapeutic Antibodies : Methods and Protocols (Methods in Molecular Biology)

治療用抗体：方法・プロトコル<br>Therapeutic Antibodies : Methods and Protocols (Methods in Molecular Biology)

個数：

治療用抗体：方法・プロトコル
Therapeutic Antibodies : Methods and Protocols (Methods in Molecular Biology)

Houen, Gunnar (EDT)

ウェブストア価格 ¥39,787（本体¥36,170）
Springer-Verlag New York Inc.（2021/09発売）
外貨定価 US$ 179.99
ポイント 361pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 347 p.
言語 ENG
商品コード 9781071614495
DDC分類 660

Full Description

This detailed book covers methods for studying, producing, and analyzing therapeutic antibodies, measuring their concentration, developing neutralizing antibodies for them, and for predicting and monitoring their therapeutic efficacy and clinical effects. These biologics are the fastest growing pharmaceutical drug group and have had tremendous clinical and scientific impact in cancer, autoimmune diseases, infectious diseases, and other immune-related diseases, making the content of this volume essential. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible methods, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Therapeutic Antibodies: Methods and Protocols serves as an ideal guide for researchers working with the production of, research on, and development of therapeutic antibodies as well as for clinicians using therapeutic antibodies in daily work with patients.

Therapeutic Antibodies: An Overview.- Treatment of Autoimmune Diseases with Therapeutic Antibodies: Lessons Learned from PID Patients Allow for Stratification of the Infection Risk.- B-Cell Analysis for Monitoring Patients Undergoing B-Cell Depletion for the Treatment of Autoimmune Diseases.- Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.- The Therapeutic Antibody Profiler for Computational Developability Assessment.- Short Read-Length Next-Generation DNA Sequencing of Antibody CDR Combinations from Phage Selection Outputs.- Large Scale Transient Production in ExpiCHO-STM with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection.- Production of Therapeutic Single-Chain Variable Fragments (ScFv) in Pichia pastoris.- Purification of Therapeutic Antibodies by Protein A Affinity Chromatography.- Ion Exchange Chromatographic Methods for Purification of Therapeutic Antibodies.- Structure-Indicated LC-MS/MS Bioanalysis of Therapeutic Antibodies.- Use of PASEF for Accelerated Protein Sequence Confirmation and De Novo Sequencing with High Data Quality.- Nano-Microscopy of Therapeutic Antibody Aggregates in Solution.- Measuring Self-Association of Antibody Lead Candidates with Dynamic Light Scattering.- Intact Mass Quantitation of Therapeutic Antibodies for Pharmacokinetic Studies Using Immuno-Purification.- Detection of Residual Host Cell Proteins in Biotherapeutic Drugs by Concatenated 2D LC-MS/MS.- Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies.- Methods for Functional Characterization of FcRn Interactions with Therapeutic Antibodies and Fc-Fusion Proteins.- Method for Measurement of Antibody-Dependent Cellular Phagocytosis.- Bioluminescent Bridging Immunoassay for Anti-Drug Antibody (ADA) Detection.- A Surface Plasmon Resonance-Based Assay for Simultaneous Measurement of Serum Concentrations of Therapeutic Antibodies and Anti-Drug Antibodies.